• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血液和尿液中硫利达嗪的测定。

Measurement of thioridazine in blood and urine.

作者信息

Ng C H, Crammer J L

出版信息

Br J Clin Pharmacol. 1977 Apr;4(2):173-83. doi: 10.1111/j.1365-2125.1977.tb00691.x.

DOI:10.1111/j.1365-2125.1977.tb00691.x
PMID:16633
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1429017/
Abstract

1 Thioridazine can be specifically, simply, and reliably measured in plasma and urine by gas chromatography using hexane extraction and prochlorperazine as internal standard; fluorimetry is non-specific. 2 The method can also measure thioridazine ring sulphoxide, and mesoridazine-plus-sulphoridazine (M/S). 3 After single doses plasma sometimes shows M/S in addition to thioridazine itself; it always does so on continued treatment. There is great individual variation in both components, and evidence of changes in metabolism during the early weeks. 4 Urinary excretion may be influenced by pH, but between pH 6.0-7.0 about 1% of the daily dose appears in 24 h urine as the following: free thioridazine in microng quantities, M/S and ring sulphoxide each in mg amounts. 5 Patients attain steady state conditions, although plasma levels rise considerably after each dose and settle again in about 10 h. After chronic treatment is stopped to half-life is at about 30 h. 6 Plasma levels cannot be related to therapeutic response when this is slow, as in schizophrenia, but interpretations are complicated by the production of clinically active metabolites, and by plasma protein binding.

摘要
  1. 采用己烷萃取并用丙氯拉嗪作为内标,通过气相色谱法可在血浆和尿液中特异性、简单且可靠地测定硫利达嗪;荧光测定法是非特异性的。2. 该方法还可测定硫利达嗪环亚砜以及美索达嗪加硫利达嗪(M/S)。3. 单次给药后,血浆中除硫利达嗪本身外有时还会出现M/S;持续治疗时则总会出现。两种成分个体差异很大,且在最初几周有代谢变化的证据。4. 尿液排泄可能受pH值影响,但在pH 6.0至7.0之间,约1%的日剂量会在24小时尿液中以如下形式出现:微量的游离硫利达嗪、毫克量的M/S和环亚砜。5. 患者达到稳态,尽管每次给药后血浆水平会大幅上升并在约10小时后再次稳定。长期治疗停药后,半衰期约为30小时。6. 当治疗反应缓慢时,如在精神分裂症中,血浆水平与治疗反应无关,但由于临床活性代谢物的产生以及血浆蛋白结合,解释变得复杂。

相似文献

1
Measurement of thioridazine in blood and urine.血液和尿液中硫利达嗪的测定。
Br J Clin Pharmacol. 1977 Apr;4(2):173-83. doi: 10.1111/j.1365-2125.1977.tb00691.x.
2
Sulphoxide metabolites of thioridazine in man.
Xenobiotica. 1986 Dec;16(12):1097-107. doi: 10.3109/00498258609038987.
3
A pilot of plasma thioridazine and metabolites in chronically treated patients.慢性治疗患者中硫利达嗪血浆及其代谢物的一项试点研究。
Br J Psychiatry. 1980 Jun;136:591-6. doi: 10.1192/bjp.136.6.591.
4
Metabolism of piperidine-type phenothiazine antipsychotic agents. IV. Thioridazine in dog, man and rat.
Xenobiotica. 1993 Oct;23(10):1059-74. doi: 10.3109/00498259309059422.
5
Phenolic metabolites of thioridazine in man.
Xenobiotica. 1985 Apr;15(4):309-16. doi: 10.3109/00498258509045365.
6
Red blood cell and plasma levels of thioridazine and mesoridazine in schizophrenic patients.精神分裂症患者中硫利达嗪和甲硫哒嗪的红细胞及血浆水平
Psychopharmacology (Berl). 1984;82(1-2):55-61. doi: 10.1007/BF00426381.
7
Plasma levels of thioridazine and metabolites are influenced by the debrisoquin hydroxylation phenotype.
Clin Pharmacol Ther. 1991 Mar;49(3):234-40. doi: 10.1038/clpt.1991.22.
8
Plasma levels and half lives of thioridazine and some of its metabolites. II. Low doses in older psychiatric patients.
Eur J Clin Pharmacol. 1977 Jan 3;11(2):141-7. doi: 10.1007/BF00562906.
9
Light-induced racemization: artifacts in the analysis of the diastereoisomeric pairs of thioridazine 5-sulfoxide in the plasma and urine of patients treated with thioridazine.光致消旋化:接受硫利达嗪治疗患者血浆和尿液中硫利达嗪5-亚砜非对映异构体对分析中的假象。
Ther Drug Monit. 1991 Jul;13(4):356-62.
10
Absorption and excretion of thioridazine and mesoridazine in man.硫利达嗪和甲砜达嗪在人体中的吸收与排泄
Dis Nerv Syst. 1974 Nov;35(11):494-6.

引用本文的文献

1
A phase 1 trial evaluating thioridazine in combination with cytarabine in patients with acute myeloid leukemia.一项评估硫利达嗪联合阿糖胞苷治疗急性髓系白血病患者的 1 期临床试验。
Blood Adv. 2018 Aug 14;2(15):1935-1945. doi: 10.1182/bloodadvances.2018015677.
2
Fluoxetine and thioridazine inhibit efflux and attenuate crystalline biofilm formation by Proteus mirabilis.氟西汀和硫利达嗪抑制变形杆菌的外排并减弱其晶体生物膜的形成。
Sci Rep. 2017 Sep 22;7(1):12222. doi: 10.1038/s41598-017-12445-w.
3
Red blood cell and plasma levels of thioridazine and mesoridazine in schizophrenic patients.精神分裂症患者中硫利达嗪和甲硫哒嗪的红细胞及血浆水平
Psychopharmacology (Berl). 1984;82(1-2):55-61. doi: 10.1007/BF00426381.
4
The biotransformation of thioridazine to thioridazine 5-sulfoxide stereoisomers in phenobarbital induced rats.
Eur J Drug Metab Pharmacokinet. 1986 Oct-Dec;11(4):283-9. doi: 10.1007/BF03189113.
5
Plasma level monitoring of antipsychotic drugs.抗精神病药物的血药浓度监测
Clin Pharmacokinet. 1978 Jan-Feb;3(1):14-38. doi: 10.2165/00003088-197803010-00002.

本文引用的文献

1
THE EXCRETION AND METABOLISM OF 35S-LABELED THIORIDAZINE IN URINE, BLOOD, BILE, AND FECES.
Biochem Pharmacol. 1963 Dec;12:1429-35. doi: 10.1016/0006-2952(63)90213-2.
2
A method for the fluorimetric determination of thioridazine (Mellaril) or mesoridazine (Lidanil) in plasma.一种荧光法测定血浆中硫利达嗪(美立廉)或甲砜达嗪(利多尼)的方法。
Experientia. 1969 Jan 15;25(1):103-4. doi: 10.1007/BF01903925.
3
Chlorpromazine: concentrations in plasma, excretion in urine and duration of effect.氯丙嗪:血浆浓度、尿排泄及作用持续时间。
Proc R Soc Med. 1971 Mar;64(3):285-9. doi: 10.1177/003591577106400323.
4
Plasma concentrations of thioridazine in patients with depression. A preliminary report.
Acta Psychiatr Scand. 1970;46(4):360-4. doi: 10.1111/j.1600-0447.1970.tb02125.x.
5
Serum levels of thioridazine in psychiatric patients and healthy volunteers.精神病患者和健康志愿者的硫利达嗪血清水平。
Eur J Clin Pharmacol. 1973 Oct;6(3):181-6. doi: 10.1007/BF00558283.
6
Therapeutic effect and plasma level of thioridazine.
Acta Psychiatr Scand. 1973;49(5):535-45. doi: 10.1111/j.1600-0447.1973.tb04445.x.
7
Mesoridazine versus chlorpromazine in acute schizophrenia: a double-blind investigation.美索达嗪与氯丙嗪治疗急性精神分裂症的双盲研究
Am J Psychiatry. 1973 Jun;130(6):689-92. doi: 10.1176/ajp.130.6.689.
8
Theoretical changes in drug distribution resulting from changes in binding to plasma proteins and to tissues.
J Pharm Pharmacol. 1970 Oct;22(10):753-7. doi: 10.1111/j.2042-7158.1970.tb08423.x.
9
Gas chromatographic identification of thioridazine in plasma, and a method for routine assay of the drug.
J Pharm Pharmacol. 1969 Oct;21(10):674-7. doi: 10.1111/j.2042-7158.1969.tb08144.x.
10
Albumin binding of thioridazine and some of its metabolites.硫利达嗪及其某些代谢物的白蛋白结合情况。
Arch Int Pharmacodyn Ther. 1975 Mar;214(1):86-91.